0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Animal Softgel Capsules Market Research Report 2026
Published Date: 2026-04-13
|
Report Code: QYRE-Auto-29J8908
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Non Animal Softgel Capsules Market Outlook 2022
BUY CHAPTERS

Global Non-Animal Softgel Capsules Market Research Report 2026

Code: QYRE-Auto-29J8908
Report
2026-04-13
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-Animal Softgel Capsules Market Size

The global Non-Animal Softgel Capsules market was valued at US$ 455 million in 2025 and is anticipated to reach US$ 638 million by 2032, at a CAGR of 5.0% from 2026 to 2032.

Non-Animal Softgel Capsules Market

Non-Animal Softgel Capsules Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Non-Animal Softgel Capsules competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.
Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world. Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively. Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales. This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products.
This report delivers a comprehensive overview of the global Non-Animal Softgel Capsules market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Non-Animal Softgel Capsules. The Non-Animal Softgel Capsules market size, estimates, and forecasts are provided in terms of sales volume (M Capsules) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Non-Animal Softgel Capsules market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Non-Animal Softgel Capsules manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Non-Animal Softgel Capsules Market Report

Report Metric Details
Report Name Non-Animal Softgel Capsules Market
Accounted market size in 2025 US$ 455 million
Forecasted market size in 2032 US$ 638 million
CAGR 5.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Carrageenan Softgel
  • Starch Softgel
  • Gellan Gum Softgel
by Application
  • Health Supplements
  • Pharmaceutical
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Catalent, Procaps Laboratorios, EuroCaps, Baihe, Aenova, Captek, Sirio, Bahrain Pharma, Robinson Pharma, Aland, Fuji Capsule, Sunsho Pharmaceutical, Erkang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Non-Animal Softgel Capsules manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Non-Animal Softgel Capsules sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Non-Animal Softgel Capsules Market growing?

Ans: The Non-Animal Softgel Capsules Market witnessing a CAGR of 5.0% during the forecast period 2026-2032.

What is the Non-Animal Softgel Capsules Market size in 2032?

Ans: The Non-Animal Softgel Capsules Market size in 2032 will be US$ 638 million.

What is the Non-Animal Softgel Capsules Market share by region?

Ans: Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively.

Who are the main players in the Non-Animal Softgel Capsules Market report?

Ans: The main players in the Non-Animal Softgel Capsules Market are Catalent, Procaps Laboratorios, EuroCaps, Baihe, Aenova, Captek, Sirio, Bahrain Pharma, Robinson Pharma, Aland, Fuji Capsule, Sunsho Pharmaceutical, Erkang

What are the Application segmentation covered in the Non-Animal Softgel Capsules Market report?

Ans: The Applications covered in the Non-Animal Softgel Capsules Market report are Health Supplements, Pharmaceutical, Others

What are the Type segmentation covered in the Non-Animal Softgel Capsules Market report?

Ans: The Types covered in the Non-Animal Softgel Capsules Market report are Carrageenan Softgel, Starch Softgel, Gellan Gum Softgel

1 Non-Animal Softgel Capsules Market Overview
1.1 Product Definition
1.2 Non-Animal Softgel Capsules by Type
1.2.1 Global Non-Animal Softgel Capsules Market Value by Type: 2025 vs 2032
1.2.2 Carrageenan Softgel
1.2.3 Starch Softgel
1.2.4 Gellan Gum Softgel
1.3 Non-Animal Softgel Capsules by Application
1.3.1 Global Non-Animal Softgel Capsules Market Value by Application: 2025 vs 2032
1.3.2 Health Supplements
1.3.3 Pharmaceutical
1.3.4 Others
1.4 Global Non-Animal Softgel Capsules Market Size Estimates and Forecasts
1.4.1 Global Non-Animal Softgel Capsules Revenue 2021–2032
1.4.2 Global Non-Animal Softgel Capsules Sales 2021–2032
1.4.3 Global Non-Animal Softgel Capsules Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Non-Animal Softgel Capsules Market Competition by Manufacturers
2.1 Global Non-Animal Softgel Capsules Sales Market Share by Manufacturers (2021–2026)
2.2 Global Non-Animal Softgel Capsules Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Non-Animal Softgel Capsules Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Non-Animal Softgel Capsules, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Non-Animal Softgel Capsules, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Non-Animal Softgel Capsules, Product Types and Applications
2.7 Global Key Manufacturers of Non-Animal Softgel Capsules, Date of Entry into the Industry
2.8 Global Non-Animal Softgel Capsules Market Competitive Situation and Trends
2.8.1 Global Non-Animal Softgel Capsules Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Non-Animal Softgel Capsules Players Market Share by Revenue
2.8.3 Global Non-Animal Softgel Capsules Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-Animal Softgel Capsules Market Scenario by Region
3.1 Global Non-Animal Softgel Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Non-Animal Softgel Capsules Sales by Region: 2021–2032
3.2.1 Global Non-Animal Softgel Capsules Sales by Region: 2021–2026
3.2.2 Global Non-Animal Softgel Capsules Sales by Region: 2027–2032
3.3 Global Non-Animal Softgel Capsules Revenue by Region: 2021–2032
3.3.1 Global Non-Animal Softgel Capsules Revenue by Region: 2021–2026
3.3.2 Global Non-Animal Softgel Capsules Revenue by Region: 2027–2032
3.4 North America Non-Animal Softgel Capsules Market Facts & Figures by Country
3.4.1 North America Non-Animal Softgel Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Non-Animal Softgel Capsules Sales by Country (2021–2032)
3.4.3 North America Non-Animal Softgel Capsules Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Animal Softgel Capsules Market Facts & Figures by Country
3.5.1 Europe Non-Animal Softgel Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Non-Animal Softgel Capsules Sales by Country (2021–2032)
3.5.3 Europe Non-Animal Softgel Capsules Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Animal Softgel Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Non-Animal Softgel Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Non-Animal Softgel Capsules Sales by Region (2021–2032)
3.6.3 Asia Pacific Non-Animal Softgel Capsules Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Non-Animal Softgel Capsules Market Facts & Figures by Country
3.7.1 Latin America Non-Animal Softgel Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Non-Animal Softgel Capsules Sales by Country (2021–2032)
3.7.3 Latin America Non-Animal Softgel Capsules Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Animal Softgel Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Animal Softgel Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Non-Animal Softgel Capsules Sales by Country (2021–2032)
3.8.3 Middle East and Africa Non-Animal Softgel Capsules Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Animal Softgel Capsules Sales by Type (2021–2032)
4.1.1 Global Non-Animal Softgel Capsules Sales by Type (2021–2026)
4.1.2 Global Non-Animal Softgel Capsules Sales by Type (2027–2032)
4.1.3 Global Non-Animal Softgel Capsules Sales Market Share by Type (2021–2032)
4.2 Global Non-Animal Softgel Capsules Revenue by Type (2021–2032)
4.2.1 Global Non-Animal Softgel Capsules Revenue by Type (2021–2026)
4.2.2 Global Non-Animal Softgel Capsules Revenue by Type (2027–2032)
4.2.3 Global Non-Animal Softgel Capsules Revenue Market Share by Type (2021–2032)
4.3 Global Non-Animal Softgel Capsules Price by Type (2021–2032)
5 Segment by Application
5.1 Global Non-Animal Softgel Capsules Sales by Application (2021–2032)
5.1.1 Global Non-Animal Softgel Capsules Sales by Application (2021–2026)
5.1.2 Global Non-Animal Softgel Capsules Sales by Application (2027–2032)
5.1.3 Global Non-Animal Softgel Capsules Sales Market Share by Application (2021–2032)
5.2 Global Non-Animal Softgel Capsules Revenue by Application (2021–2032)
5.2.1 Global Non-Animal Softgel Capsules Revenue by Application (2021–2026)
5.2.2 Global Non-Animal Softgel Capsules Revenue by Application (2027–2032)
5.2.3 Global Non-Animal Softgel Capsules Revenue Market Share by Application (2021–2032)
5.3 Global Non-Animal Softgel Capsules Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Catalent
6.1.1 Catalent Company Information
6.1.2 Catalent Description and Business Overview
6.1.3 Catalent Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Catalent Non-Animal Softgel Capsules Product Portfolio
6.1.5 Catalent Recent Developments/Updates
6.2 Procaps Laboratorios
6.2.1 Procaps Laboratorios Company Information
6.2.2 Procaps Laboratorios Description and Business Overview
6.2.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Procaps Laboratorios Non-Animal Softgel Capsules Product Portfolio
6.2.5 Procaps Laboratorios Recent Developments/Updates
6.3 EuroCaps
6.3.1 EuroCaps Company Information
6.3.2 EuroCaps Description and Business Overview
6.3.3 EuroCaps Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 EuroCaps Non-Animal Softgel Capsules Product Portfolio
6.3.5 EuroCaps Recent Developments/Updates
6.4 Baihe
6.4.1 Baihe Company Information
6.4.2 Baihe Description and Business Overview
6.4.3 Baihe Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Baihe Non-Animal Softgel Capsules Product Portfolio
6.4.5 Baihe Recent Developments/Updates
6.5 Aenova
6.5.1 Aenova Company Information
6.5.2 Aenova Description and Business Overview
6.5.3 Aenova Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Aenova Non-Animal Softgel Capsules Product Portfolio
6.5.5 Aenova Recent Developments/Updates
6.6 Captek
6.6.1 Captek Company Information
6.6.2 Captek Description and Business Overview
6.6.3 Captek Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Captek Non-Animal Softgel Capsules Product Portfolio
6.6.5 Captek Recent Developments/Updates
6.7 Sirio
6.7.1 Sirio Company Information
6.7.2 Sirio Description and Business Overview
6.7.3 Sirio Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sirio Non-Animal Softgel Capsules Product Portfolio
6.7.5 Sirio Recent Developments/Updates
6.8 Bahrain Pharma
6.8.1 Bahrain Pharma Company Information
6.8.2 Bahrain Pharma Description and Business Overview
6.8.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Bahrain Pharma Non-Animal Softgel Capsules Product Portfolio
6.8.5 Bahrain Pharma Recent Developments/Updates
6.9 Robinson Pharma
6.9.1 Robinson Pharma Company Information
6.9.2 Robinson Pharma Description and Business Overview
6.9.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Robinson Pharma Non-Animal Softgel Capsules Product Portfolio
6.9.5 Robinson Pharma Recent Developments/Updates
6.10 Aland
6.10.1 Aland Company Information
6.10.2 Aland Description and Business Overview
6.10.3 Aland Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Aland Non-Animal Softgel Capsules Product Portfolio
6.10.5 Aland Recent Developments/Updates
6.11 Fuji Capsule
6.11.1 Fuji Capsule Company Information
6.11.2 Fuji Capsule Description and Business Overview
6.11.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Fuji Capsule Non-Animal Softgel Capsules Product Portfolio
6.11.5 Fuji Capsule Recent Developments/Updates
6.12 Sunsho Pharmaceutical
6.12.1 Sunsho Pharmaceutical Company Information
6.12.2 Sunsho Pharmaceutical Description and Business Overview
6.12.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Portfolio
6.12.5 Sunsho Pharmaceutical Recent Developments/Updates
6.13 Erkang
6.13.1 Erkang Company Information
6.13.2 Erkang Description and Business Overview
6.13.3 Erkang Non-Animal Softgel Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Erkang Non-Animal Softgel Capsules Product Portfolio
6.13.5 Erkang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Animal Softgel Capsules Industry Chain Analysis
7.2 Non-Animal Softgel Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Animal Softgel Capsules Production Mode & Process Analysis
7.4 Non-Animal Softgel Capsules Sales and Marketing
7.4.1 Non-Animal Softgel Capsules Sales Channels
7.4.2 Non-Animal Softgel Capsules Distributors
7.5 Non-Animal Softgel Capsules Customer Analysis
8 Non-Animal Softgel Capsules Market Dynamics
8.1 Non-Animal Softgel Capsules Industry Trends
8.2 Non-Animal Softgel Capsules Market Drivers
8.3 Non-Animal Softgel Capsules Market Challenges
8.4 Non-Animal Softgel Capsules Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Non-Animal Softgel Capsules Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Non-Animal Softgel Capsules Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Non-Animal Softgel Capsules Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Non-Animal Softgel Capsules Sales (M Capsules) of Key Manufacturers (2021–2026)
 Table 5. Global Non-Animal Softgel Capsules Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Non-Animal Softgel Capsules Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Non-Animal Softgel Capsules Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Non-Animal Softgel Capsules Average Price (US$/Capsule) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Non-Animal Softgel Capsules, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Non-Animal Softgel Capsules, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Non-Animal Softgel Capsules, Product Types and Applications
 Table 12. Global Key Manufacturers of Non-Animal Softgel Capsules, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Non-Animal Softgel Capsules Companies by Tier (Tier 1, Tier 2, Tier 3), based on Non-Animal Softgel Capsules Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Non-Animal Softgel Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Non-Animal Softgel Capsules Sales by Region (M Capsules), 2021–2026
 Table 18. Global Non-Animal Softgel Capsules Sales Market Share by Region (2021–2026)
 Table 19. Global Non-Animal Softgel Capsules Sales by Region (M Capsules), 2027–2032
 Table 20. Global Non-Animal Softgel Capsules Sales Market Share by Region (2027–2032)
 Table 21. Global Non-Animal Softgel Capsules Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Non-Animal Softgel Capsules Revenue Market Share by Region (2021–2026)
 Table 23. Global Non-Animal Softgel Capsules Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Non-Animal Softgel Capsules Revenue Market Share by Region (2027–2032)
 Table 25. North America Non-Animal Softgel Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Non-Animal Softgel Capsules Sales by Country (M Capsules), 2021–2026
 Table 27. North America Non-Animal Softgel Capsules Sales by Country (M Capsules), 2027–2032
 Table 28. North America Non-Animal Softgel Capsules Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Non-Animal Softgel Capsules Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Non-Animal Softgel Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Non-Animal Softgel Capsules Sales by Country (M Capsules), 2021–2026
 Table 32. Europe Non-Animal Softgel Capsules Sales by Country (M Capsules), 2027–2032
 Table 33. Europe Non-Animal Softgel Capsules Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Non-Animal Softgel Capsules Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Non-Animal Softgel Capsules Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Non-Animal Softgel Capsules Sales by Region (M Capsules), 2021–2026
 Table 37. Asia Pacific Non-Animal Softgel Capsules Sales by Region (M Capsules), 2027–2032
 Table 38. Asia Pacific Non-Animal Softgel Capsules Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Non-Animal Softgel Capsules Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Non-Animal Softgel Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Non-Animal Softgel Capsules Sales by Country (M Capsules), 2021–2026
 Table 42. Latin America Non-Animal Softgel Capsules Sales by Country (M Capsules), 2027–2032
 Table 43. Latin America Non-Animal Softgel Capsules Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Non-Animal Softgel Capsules Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Non-Animal Softgel Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Non-Animal Softgel Capsules Sales by Country (M Capsules), 2021–2026
 Table 47. Middle East and Africa Non-Animal Softgel Capsules Sales by Country (M Capsules), 2027–2032
 Table 48. Middle East and Africa Non-Animal Softgel Capsules Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Non-Animal Softgel Capsules Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Non-Animal Softgel Capsules Sales (M Capsules) by Type (2021–2026)
 Table 51. Global Non-Animal Softgel Capsules Sales (M Capsules) by Type (2027–2032)
 Table 52. Global Non-Animal Softgel Capsules Sales Market Share by Type (2021–2026)
 Table 53. Global Non-Animal Softgel Capsules Sales Market Share by Type (2027–2032)
 Table 54. Global Non-Animal Softgel Capsules Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Non-Animal Softgel Capsules Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Non-Animal Softgel Capsules Revenue Market Share by Type (2021–2026)
 Table 57. Global Non-Animal Softgel Capsules Revenue Market Share by Type (2027–2032)
 Table 58. Global Non-Animal Softgel Capsules Price (US$/Capsule) by Type (2021–2026)
 Table 59. Global Non-Animal Softgel Capsules Price (US$/Capsule) by Type (2027–2032)
 Table 60. Global Non-Animal Softgel Capsules Sales (M Capsules) by Application (2021–2026)
 Table 61. Global Non-Animal Softgel Capsules Sales (M Capsules) by Application (2027–2032)
 Table 62. Global Non-Animal Softgel Capsules Sales Market Share by Application (2021–2026)
 Table 63. Global Non-Animal Softgel Capsules Sales Market Share by Application (2027–2032)
 Table 64. Global Non-Animal Softgel Capsules Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Non-Animal Softgel Capsules Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Non-Animal Softgel Capsules Revenue Market Share by Application (2021–2026)
 Table 67. Global Non-Animal Softgel Capsules Revenue Market Share by Application (2027–2032)
 Table 68. Global Non-Animal Softgel Capsules Price (US$/Capsule) by Application (2021–2026)
 Table 69. Global Non-Animal Softgel Capsules Price (US$/Capsule) by Application (2027–2032)
 Table 70. Catalent Company Information
 Table 71. Catalent Description and Business Overview
 Table 72. Catalent Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 73. Catalent Non-Animal Softgel Capsules Product
 Table 74. Catalent Recent Developments/Updates
 Table 75. Procaps Laboratorios Company Information
 Table 76. Procaps Laboratorios Description and Business Overview
 Table 77. Procaps Laboratorios Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 78. Procaps Laboratorios Non-Animal Softgel Capsules Product
 Table 79. Procaps Laboratorios Recent Developments/Updates
 Table 80. EuroCaps Company Information
 Table 81. EuroCaps Description and Business Overview
 Table 82. EuroCaps Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 83. EuroCaps Non-Animal Softgel Capsules Product
 Table 84. EuroCaps Recent Developments/Updates
 Table 85. Baihe Company Information
 Table 86. Baihe Description and Business Overview
 Table 87. Baihe Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 88. Baihe Non-Animal Softgel Capsules Product
 Table 89. Baihe Recent Developments/Updates
 Table 90. Aenova Company Information
 Table 91. Aenova Description and Business Overview
 Table 92. Aenova Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 93. Aenova Non-Animal Softgel Capsules Product
 Table 94. Aenova Recent Developments/Updates
 Table 95. Captek Company Information
 Table 96. Captek Description and Business Overview
 Table 97. Captek Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 98. Captek Non-Animal Softgel Capsules Product
 Table 99. Captek Recent Developments/Updates
 Table 100. Sirio Company Information
 Table 101. Sirio Description and Business Overview
 Table 102. Sirio Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 103. Sirio Non-Animal Softgel Capsules Product
 Table 104. Sirio Recent Developments/Updates
 Table 105. Bahrain Pharma Company Information
 Table 106. Bahrain Pharma Description and Business Overview
 Table 107. Bahrain Pharma Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 108. Bahrain Pharma Non-Animal Softgel Capsules Product
 Table 109. Bahrain Pharma Recent Developments/Updates
 Table 110. Robinson Pharma Company Information
 Table 111. Robinson Pharma Description and Business Overview
 Table 112. Robinson Pharma Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 113. Robinson Pharma Non-Animal Softgel Capsules Product
 Table 114. Robinson Pharma Recent Developments/Updates
 Table 115. Aland Company Information
 Table 116. Aland Description and Business Overview
 Table 117. Aland Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 118. Aland Non-Animal Softgel Capsules Product
 Table 119. Aland Recent Developments/Updates
 Table 120. Fuji Capsule Company Information
 Table 121. Fuji Capsule Description and Business Overview
 Table 122. Fuji Capsule Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 123. Fuji Capsule Non-Animal Softgel Capsules Product
 Table 124. Fuji Capsule Recent Developments/Updates
 Table 125. Sunsho Pharmaceutical Company Information
 Table 126. Sunsho Pharmaceutical Description and Business Overview
 Table 127. Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 128. Sunsho Pharmaceutical Non-Animal Softgel Capsules Product
 Table 129. Sunsho Pharmaceutical Recent Developments/Updates
 Table 130. Erkang Company Information
 Table 131. Erkang Description and Business Overview
 Table 132. Erkang Non-Animal Softgel Capsules Sales (M Capsules), Revenue (US$ Million), Price (US$/Capsule), and Gross Margin (2021–2026)
 Table 133. Erkang Non-Animal Softgel Capsules Product
 Table 134. Erkang Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Non-Animal Softgel Capsules Distributors List
 Table 138. Non-Animal Softgel Capsules Customers List
 Table 139. Non-Animal Softgel Capsules Market Trends
 Table 140. Non-Animal Softgel Capsules Market Drivers
 Table 141. Non-Animal Softgel Capsules Market Challenges
 Table 142. Non-Animal Softgel Capsules Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Non-Animal Softgel Capsules
 Figure 2. Global Non-Animal Softgel Capsules Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Non-Animal Softgel Capsules Market Share by Type: 2025 & 2032
 Figure 4. Carrageenan Softgel Product Picture
 Figure 5. Starch Softgel Product Picture
 Figure 6. Gellan Gum Softgel Product Picture
 Figure 7. Global Non-Animal Softgel Capsules Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Non-Animal Softgel Capsules Market Share by Application: 2025 & 2032
 Figure 9. Health Supplements
 Figure 10. Pharmaceutical
 Figure 11. Others
 Figure 12. Global Non-Animal Softgel Capsules Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Non-Animal Softgel Capsules Market Size (US$ Million), 2021–2032
 Figure 14. Global Non-Animal Softgel Capsules Sales (M Capsules), 2021–2032
 Figure 15. Global Non-Animal Softgel Capsules Average Price (US$/Capsule), 2021–2032
 Figure 16. Non-Animal Softgel Capsules Report Years Considered
 Figure 17. Non-Animal Softgel Capsules Sales Share by Manufacturers in 2025
 Figure 18. Global Non-Animal Softgel Capsules Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Non-Animal Softgel Capsules Players: Market Share by Revenue in Non-Animal Softgel Capsules in 2025
 Figure 20. Non-Animal Softgel Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Non-Animal Softgel Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Non-Animal Softgel Capsules Sales Market Share by Country (2021–2032)
 Figure 23. North America Non-Animal Softgel Capsules Revenue Market Share by Country (2021–2032)
 Figure 24. United States Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Non-Animal Softgel Capsules Sales Market Share by Country (2021–2032)
 Figure 27. Europe Non-Animal Softgel Capsules Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Non-Animal Softgel Capsules Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Non-Animal Softgel Capsules Revenue Market Share by Region (2021–2032)
 Figure 35. China Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Non-Animal Softgel Capsules Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Non-Animal Softgel Capsules Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Non-Animal Softgel Capsules Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Non-Animal Softgel Capsules Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Non-Animal Softgel Capsules Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Non-Animal Softgel Capsules by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Non-Animal Softgel Capsules by Type (2021–2032)
 Figure 56. Global Non-Animal Softgel Capsules Price (US$/Capsule) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Non-Animal Softgel Capsules by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Non-Animal Softgel Capsules by Application (2021–2032)
 Figure 59. Global Non-Animal Softgel Capsules Price (US$/Capsule) by Application (2021–2032)
 Figure 60. Non-Animal Softgel Capsules Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners